Ontrak Health Sets New Standard in Behavioral Health Care with Implementation of ReQoL Assessment in the US

2024-02-27
MIAMI--(BUSINESS WIRE)--Ontrak Health (NASDAQ: OTRK), a leading AI-powered and telehealth-enabled healthcare company, has achieved a new milestone by introducing the Recovering Quality of Life Assessment (ReQoL) into its cutting-edge WholeHealth+ Product and Solutions Suite. This strategic advancement developed by the Oxford University Innovation Lab underscores Ontrak Health's commitment to transforming mental health care through continuous improvement, reinforcing its position as a leader in personalized and effective evidence-based solutions for mental health.
'The integration of ReQoL aligns seamlessly with our commitment to delivering person-centric measurement-based care to people with mental health and substance use conditions. It\'s a testament to our dedication to innovation, blending clinical excellence with coaching feedback for durable outcomes.'
Recognizing the limitations of existing measures in assessing the quality of life for people with different mental health conditions, the development of ReQoL fills a critical need. ReQoL assessments can be used in healthcare and research settings to evaluate the impact of mental health conditions, psychological interventions, and healthcare interventions on patients' lives because they focus on understanding the person over the diagnosis, consistent with recovery strategies. Integrating this tool in Ontrak's coaching program emphasizes the commitment to measurement feedback in continually improving mental health care and outcomes.
Dr. Judith Feld, Chief Medical Officer at Ontrak Health, emphasized, "The integration of ReQoL aligns seamlessly with our commitment to delivering person-centric measurement-based care to people with mental health and substance use conditions. It's a testament to our dedication to innovation, blending clinical excellence with coaching feedback for durable outcomes."
As part of its thorough piloting and implementation of ReQoL, Ontrak Health has secured official recognition from the Oxford University Innovation Lab as an authorized licensee of this Clinical Outcomes Assessment (COA).
Ontrak, Inc. is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors.
Learn more at www.ontrakhealth.com
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。